Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection
Open accessAbstract
UNLABELLED: Severe acute respiratory syndrome coronavirus (SARS-CoV) caused an acute human respiratory illness with high morbidity and mortality in 2002-2003. Several studies have demonstrated the role of neutralizing antibodies induced by the spike (S) glycoprotein in protecting susceptible hosts from lethal infection. However, the anti-SARS-CoV antibody response is short-lived in patients who have recovered from SARS, making it critical to develop additional vaccine strategies. SARS-CoV-specific memory CD8 T cells persisted for up to 6 years after SARS-CoV infection, a time at which memory B cells and antivirus antibodies were undetectable in individuals who had recovered from SARS. In this study, we assessed the ability of virus-specific memory CD8 T cells to mediate protection against infection in the absence of SARS-CoV-specific memory CD4 T or B cells. We demonstrate that memory CD8 T cells specific for a single immunodominant epitope (S436 or S525) substantially protected 8- to 10-month-old mice from lethal SARS-CoV infection. Intravenous immunization with peptide-loaded dendritic cells (DCs) followed by intranasal boosting with recombinant vaccinia virus (rVV) encoding S436 or S525 resulted in accumulation of virus-specific memory CD8 T cells in bronchoalveolar lavage fluid (BAL), lungs, and spleen. Upon challenge with a lethal dose of SARS-CoV, virus-specific memory CD8 T cells efficiently produced multiple effector cytokines (gamma interferon [IFN-γ], tumor necrosis factor alpha [TNF-α], and interleukin 2 [IL-2]) and cytolytic molecules (granzyme B) and reduced lung viral loads. Overall, our results show that SARS-CoV-specific memory CD8 T cells protect susceptible hosts from lethal SARS-CoV infection, but they also suggest that SARS-CoV-specific CD4 T cell and antibody responses are necessary for complete protection. IMPORTANCE: Virus-specific CD8 T cells are required for pathogen clearance following primary SARS-CoV infection. However, the role of SARS-CoV-specific memory CD8 T cells in mediating protection after SARS-CoV challenge has not been previously investigated. In this study, using a prime-boost immunization approach, we showed that virus-specific CD8 T cells protect susceptible 8- to 10-month-old mice from lethal SARS-CoV challenge. Thus, future vaccines against emerging coronaviruses should emphasize the generation of a memory CD8 T cell response for optimal protection.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Anti-S T-cell responses to SARS- and MERS-CoVs contribute toward viral clearance in normal as well as aged mice infected with SARS- or MERS-CoV, respectively.
“anti-S T-cell responses to the related SARS- and MERS-CoVs contribute toward viral clearance in normal as well as aged mice infected with SARS- or MERS-CoV, respectively (43–45).”
From An <i>Alphavirus</i> -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates (2020) · cites this paper as [45]
The Results report that responses to the SARS-CoV spike epitopes S436 and S525 accelerated viral clearance in 8- to 10-month-old mice. The Discussion says virus-specific CD8 T cells are important for MERS-CoV clearance, but does not establish that those cells target spike or that the finding applies to both young and aged MERS-CoV-infected mice. (LLM, conf=0.87)
Experimental — accuracy not yet measuredMemory T cells, particularly those residing at the upper airways, might limit disease severity and shorten the duration of disease by rapidly eliminating infected cells and coordinating the production of antibodies.
“Memory T cells, particularly those residing at the upper airways might limit disease severity and shorten the duration of disease by rapidly eliminating infected cells and coordinating the production of antibodies [67]”
From The dawn of mRNA vaccines: the COVID-19 case (2021) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Home visits: a strategy to improve newborn survival - Authors' reply
(2008) · Americanae (AECID Library) · doi:10.1016/s0140 · Cited by 22,524 · see citing works
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677 · see citing works
T-cell quality in memory and protection: implications for vaccine design
Seder, R. A., Darrah, P. A., & Roederer, M. (2008) · Nature reviews. Immunology · doi:10.1038/nri2274 · Cited by 1,541 · see citing works
Severe acute respiratory syndrome
Peiris, M. J. S., Guan, Y., & Yuen, K. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,135 · see citing works
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
Kuiken, T., Fouchier, R. A. M., Schutten, M., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D. A. J., Laman, J. D., de Jong, T., van Doornum, G., Lim, W. W. L., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13967-0 · Cited by 1,015 · see citing works
Koch's postulates fulfilled for SARS virus
Fouchier, R. A. M., Kuiken, T., Schutten, M., van Amerongen, G., van Doornum, G. J. J., van den Hoogen, B. G., Peiris, M. J. S., Lim, W. W. L., Stöhr, K., & Osterhaus, A. D. M. E. (2003) · Nature · doi:10.1038/423240a · Cited by 790 · see citing works
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
Yang, Z.-Y., Kong, W., Huang, Y., Roberts, A., Murphy, B., Subbarao, K., & Nabel, G. (2004) · Nature · doi:10.1038/nature02463 · Cited by 688 · see citing works
A decade after SARS: strategies for controlling emerging coronaviruses
Graham, R. L., Donaldson, E., & Baric, R. S. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3143 · Cited by 676 · see citing works
Sensing and alarm function of resident memory CD8+ T cells
Schenkel, J., Fraser, K. A., Vezys, V., & Masopust, D. (2013) · Nature Immunology · doi:10.1038/ni.2568 · Cited by 648 · see citing works
Teijaro, J. R., Turner, D., Pham, Q., Wherry, E. J., Lefrançois, L., & Farber, D. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102243 · Cited by 641 · see citing works
Shaping and reshaping CD8+ T-cell memory
Harty, J. T., & Badovinac, V. P. (2008) · Nature reviews. Immunology · doi:10.1038/nri2251 · Cited by 548 · see citing works
Wu, T., Hu, Y., Lee, Y.-T., Bouchard, K. R., Benechet, A. P., Khanna, K., & Cauley, L. S. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.0313180 · Cited by 537 · see citing works
T cell-mediated immune response to respiratory coronaviruses
Channappanavar, R., Zhao, J., & Perlman, S. (2014) · Immunologic Research · doi:10.1007/s12026-014-8534-z · Cited by 512 · see citing works
Tang, F., Quan, Y., Xin, Z.-T., Wrammert, J., Ma, M.-J., Lv, H., Wang, T.-B., Yang, H., Richardus, J. H., Liu, W., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903490 · Cited by 496 · see citing works
Dendritic Cell-Induced Memory T Cell Activation in Nonlymphoid Tissues
Wakim, L., Waithman, J., van Rooijen, N., Heath, W., & Carbone, F. (2008) · Science · doi:10.1126/science.1151869 · Cited by 473 · see citing works
Rapid generation of a mouse model for Middle East respiratory syndrome
Zhao, J., Li, K., Wohlford-Lenane, C., Agnihothram, S., Fett, C., Zhao, J., Gale, M., Baric, R. S., Enjuanes, L., Gallagher, T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323279111 · Cited by 452 · see citing works
MacLeod (2008) · Bristol Research (University of Bristol) · doi:10.4049/jimmunol · Cited by 448 · see citing works
A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice
Roberts, A., Deming, D., Paddock, C. D., Cheng, A., Yount, B. L., Vogel, L., Herman, B. D., Sheahan, T., Heise, M. T., Genrich, G. L., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030005 · Cited by 447 · see citing works
Cutting Edge: Rapid In Vivo Killing by Memory CD8 T Cells
Barber, D. L., Wherry, E. J., & Ahmed, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.27 · Cited by 444 · see citing works
DeDiego, M. L., Álvarez, E. A., Almazán, F., Rejas, M. T., Lamirande, E. W., Roberts, A., Shieh, W., Zaki, S. R., Subbarao, K., & Enjuanes, L. (2006) · Journal of Virology · doi:10.1128/jvi.01467-06 · Cited by 428 · see citing works
Duration of Antibody Responses after Severe Acute Respiratory Syndrome
Wu, L.-P., Wang, N.-C., Chang, Y.-H., Tian, X.-Y., Na, D.-Y., Zhang, L.-Y., Zheng, L., Lan, T., Wang, L.-F., & Liang, G.-D. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1310.070576 · Cited by 426 · see citing works
Hogan, R. J., Usherwood, E. J., Zhong, W., Roberts, A. D., Dutton, R. W., Harmsen, A. G., & Woodland, D. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1813 · Cited by 409 · see citing works
Chen, J., Lau, Y. F., Lamirande, E. W., Paddock, C. D., Bartlett, J. H., Zaki, S. R., & Subbarao, K. (2009) · Journal of Virology · doi:10.1128/jvi.01281-09 · Cited by 400 · see citing works
Zhao, J., Zhao, J., & Perlman, S. (2010) · Journal of Virology · doi:10.1128/jvi.01049-10 · Cited by 340 · see citing works
Self-citationDendritic Cells Maximize the Memory CD8 T Cell Response to Infection
Zammit, D. J., Cauley, L. S., Pham, Q.-M., & Lefrançois, L. (2005) · Immunity · doi:10.1016/j.immuni.2005.03.005 · Cited by 324 · see citing works
Deming, D., Sheahan, T. P., Heise, M. T., Yount, B. L., Davis, N., Sims, A. M., Suthar, M. S., Harkema, J. R., Whitmore, A. C., Pickles, R. J., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030525 · Cited by 272 · see citing works
Effects of a SARS-associated coronavirus vaccine in monkeys
Gao, W., Tamin, A., Soloff, A. C., D’Aiuto, L., Nwanegbo, E. C., Robbins, P. D., Bellini, W. J., Barratt‐Boyes, S. M., & Gambotto, A. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14962-8 · Cited by 271 · see citing works
Zhao, J., Zhao, J., Legge, K., & Perlman, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59777 · Cited by 265 · see citing works
Self-citationImmunity to Respiratory Viruses
Kohlmeier, J. E., & Woodland, D. L. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132625 · Cited by 254 · see citing works
Belz, G. T., Xie, W., Altman, J. D., & Doherty, P. C. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3486-3493.2000 · Cited by 253 · see citing works
Kohlmeier, J. E., Cookenham, T. S., Roberts, A. D., Miller, S. C., & Woodland, D. L. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.016 · Cited by 237 · see citing works
Graham, R. L., Becker, M. M., Eckerle, L. D., Deming, M. E., Denison, M. R., & Baric, R. S. (2012) · Nature Medicine · doi:10.1038/nm.2972 · Cited by 230 · see citing works
Slütter, B., Pewe, L. L., Kaech, S. M., & Harty, J. T. (2013) · Immunity · doi:10.1016/j.immuni.2013.09.013 · Cited by 228 · see citing works
Crowe, S. R., Turner, S. J., Miller, S. C., Roberts, A. D., Rappolo, R. A., Doherty, P. C., Ely, K. H., & Woodland, D. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022151 · Cited by 218 · see citing works
Wakim, L. M., Gupta, N., Mintern, J. D., & Villadangos, J. A. (2013) · Nature Immunology · doi:10.1038/ni.2525 · Cited by 214 · see citing works
CD4 and CD8 T Cells Have Redundant But Not Identical Roles in Virus-Induced Demyelination
Wu, G. F., Dandekar, A. A., Pewe, L., & Perlman, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2278 · Cited by 192 · see citing works
Memory T Cell Populations in the Lung Airways Are Maintained by Continual Recruitment
Ely, K. H., Cookenham, T. S., Roberts, A. D., & Woodland, D. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.537 · Cited by 187 · see citing works
Williamson, J. S., & Stohlman, S. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.9.4589-4592.1990 · Cited by 185 · see citing works
Alfajaro, M., Kim, J.-Y., Barbé, L., et al. (2018) · HAL (Le Centre pour la Communication Scientifique Directe) · doi:10.1128/jvi · Cited by 183 · see citing works
Woo, P. C. Y., Lau, S. K. P., Wong, B. H. L., Chan, K., Chu, C., Tsoi, H.-W., Huang, Y. P., Peiris, M. J. S., & Yuen, K. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.4.665-668.2004 · Cited by 177 · see citing works
Peng, H., Yang, L., Wang, L., Li, J., Huang, J., Lu, K., Koup, R. A., Bailer, R. T., & Wu, C. Y. (2006) · Virology · doi:10.1016/j.virol.2006.03.036 · Cited by 155 · see citing works
Impaired Dendritic Cell Function in Aging Leads to Defective Antitumor Immunity
Grolleau‐Julius, A., Harning, E. K., Close, L. A., & Yung, R. L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5769 · Cited by 151 · see citing works
Wlodarczyk, V., Pinabiaux, C., & Goumi, A. (2026) · HAL (Le Centre pour la Communication Scientifique Directe) · doi:10.1146/annurev · Cited by 125 · see citing works
Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease
Enjuanes, L., DeDiego, M. L., Álvarez, E. A., Deming, D., Sheahan, T., & Baric, R. S. (2007) · Virus Research · doi:10.1016/j.virusres.2007.01.021 · Cited by 119 · see citing works
b Middle East respiratory syndrome coronavirus (MERS-CoV): update
Emirates, U. A. (2014) · Cited by 119 · see citing works
Fett, C., DeDiego, M. L., Regla-Nava, J. Á., Enjuanes, L., & Perlman, S. M. (2013) · Journal of Virology · doi:10.1128/jvi.00087-13 · Cited by 118 · see citing works
Christensen, J. P., Doherty, P. C., Branum, K. C., & Riberdy, J. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11690-11696.2000 · Cited by 117 · see citing works
Antigen-Specific Regulation of T Cell–Mediated Cytokine Production
Slifka, M. K., & Whitton, J. L. (2000) · Immunity · doi:10.1016/s1074-7613(00)80197-1 · Cited by 116 · see citing works
Yang, L., Peng, H., Zhu, Z.-L., Li, G., Huang, Z., Zhao, Z., Koup, R. A., Bailer, R. T., & Wu, C. Y. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.05.002 · Cited by 115 · see citing works
Belz, G. T., Stevenson, P. G., & Doherty, P. C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2404 · Cited by 109 · see citing works
Pham, N., Badovinac, V. P., & Harty, J. T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901203 · Cited by 97 · see citing works
Middle East Respiratory Syndrome coronavirus (MERS CoV): Update 2013
Lim, P. L., Lee, T. H., & Rowe, E. K. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0344-2 · Cited by 90 · see citing works
Zhi, Y., Kobinger, G., Jordan, H. M., Suchma, K., Weiss, S. R., Shen, H., Schumer, G., Gao, G., Boyer, J. L., Crystal, R. G., et al. (2005) · Virology · doi:10.1016/j.virol.2005.01.050 · Cited by 82 · see citing works
T Cell Memory in the Lung Airways
Woodland, D. L., & Scott, I. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200501-003aw · Cited by 54 · see citing works
Yang, L., Peng, H., Zhu, Z., Li, G., Huang, Z., Zhao, Z., Koup, R. A., Bailer, R. T., & Wu, C. Y. (2007) · Journal of General Virology · doi:10.1099/vir.0.82839-0 · Cited by 53 · see citing works
Khanolkar, A., Hartwig, S. M., Haag, B. A., Meyerholz, D. K., Epping, L. L., Haring, J. S., Varga, S. M., & Harty, J. T. (2009) · Journal of Virology · doi:10.1128/jvi.00355-09 · Cited by 49 · see citing works
Slütter, B., Pewe, L. L., Lauer, P., & Harty, J. T. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202790 · Cited by 42 · see citing works
Barbero (2014) · doi:10.1016/j · Cited by 1 · see citing works
Bobisse, S., Rondina, M., Merlo, A., et al. (2008) · Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) · doi:10.1158/0008-5472 · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Cheng, L., Li, J., Wang, X., Wang, F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0901-9 · Cited by 2,614 · see citing works
Coronavirus infections and immune responses
Li, G., Fan, Y., Lai, Y., Han, T., Li, Z., Zhou, P., Pan, P., Wang, W., Hu, D., Liu, X., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25685 · Cited by 1,963 · see citing works
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788 · see citing works
Zhu, F.-C., Li, Y.-H., Guan, X.-H., Hou, L.-H., Wang, W.-J., Li, J.-X., Wu, S.-P., Wang, B.-S., Wang, Z., Wang, L., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31208-3 · Cited by 1,382 · see citing works
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Braun, J., Loyal, L., Frentsch, M., Wendisch, D., Georg, P., Kurth, F., Hippenstiel, S., Dingeldey, M., Kruse, B., Fauchere, F., et al. (2020) · Nature · doi:10.1038/s41586-020-2598-9 · Cited by 1,310 · see citing works
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Costela-Ruiz, V. J., Montes, R. I., Puerta, J. M., Ruíz, C., & Melguizo‐Rodríguez, L. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.001 · Cited by 1,110 · see citing works
Ahmed, S. F., Quadeer, A. A., & McKay, M. R. (2020) · Viruses · doi:10.3390/v12030254 · Cited by 1,116 · see citing works
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
Sahin, U., Muik, A., Vogler, I., Derhovanessian, E., Kranz, L. M., Vormehr, M., Quandt, J., Bidmon, N., Ulges, A., Baum, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03653-6 · Cited by 845 · see citing works
Liu, L., Wei, Q., Lin, Q., Fang, J., Wang, H., Kwok, H., Tang, H., Nishiura, K., Peng, J., Tan, Z., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.123158 · Cited by 830 · see citing works
COVID-19 with Different Severities: A Multicenter Study of Clinical Features
Feng, Y., Ling, Y., Bai, T., Xie, Y., Huang, J., Li, J., Xiong, W., Yang, D., Chen, R., Lu, F., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202002-0445oc · Cited by 834 · see citing works
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
Nelde, A., Bilich, T., Heitmann, J. S., Maringer, Y., Salih, H. R., Roerden, M., Lübke, M., Bauer, J., Rieth, J., Wacker, M., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00808-x · Cited by 582 · see citing works
The signal pathways and treatment of cytokine storm in COVID-19
Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 599 · see citing works
Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses
Zhou, R., To, K. K.-W., Wong, Y.-C., Liu, L., Zhou, B., Li, X., Huang, H., Mo, Y., Luk, T.-Y., Lau, T. T.-K., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.026 · Cited by 531 · see citing works
The many faces of the anti-COVID immune response
Vardhana, S. A., & Wolchok, J. D. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20200678 · Cited by 507 · see citing works
Immunological characteristics govern the transition of COVID-19 to endemicity
Lavine, J. S., Bjornstad, O. N., & Antia, R. (2021) · Science · doi:10.1126/science.abe6522 · Cited by 416 · see citing works
The dawn of mRNA vaccines: the COVID-19 case
Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.043 · Cited by 504 · see citing works
Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
Ng, O.-W., Chia, A., Tan, A. T., Jadi, R. S., Leong, H. N., Bertoletti, A., & Tan, Y.-J. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.02.063 · Cited by 436 · see citing works
Gao, T., Hu, M., Zhang, X., Li, H., Zhu, L., Liu, H., Dong, Q., Zhang, Z., Wang, Z., Hu, Y., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1101/2020.03.29.20041962 · Cited by 435 · see citing works
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
Zuo, J., Dowell, A. C., Pearce, H., Verma, K., Long, H. M., Begum, J., Aiano, F., Amin-Chowdhury, Z., Hoschler, K., Brooks, T., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00902-8 · Cited by 392 · see citing works
T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
Liu, W. J., Zhao, M. J., Liu, K., Xu, K., Wong, G., Tan, W., & Gao, G. F. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.006 · Cited by 397 · see citing works
COVID-19 vaccines: The status and perspectives in delivery points of view
Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.011 · Cited by 375 · see citing works
The CD8 T Cell Response to Respiratory Virus Infections
Schmidt, M. E., & Varga, S. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00678 · Cited by 371 · see citing works
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
Ward, B. J., Gobeil, P., Séguin, A., Atkins, J., Boulay, I., Charbonneau, P.-Y., Couture, M., D’Aoust, M., Dhaliwall, J. K., Finkle, C. D., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01370-1 · Cited by 361 · see citing works
T cell response to SARS-CoV-2 infection in humans: A systematic review
Shrotri, M., van Schalkwyk, M. C., Post, N., Eddy, D., Huntley, C., Leeman, D., Rigby, S., Williams, S. V., Bermingham, W. H., Kellam, P., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245532 · Cited by 349 · see citing works
The roles of tertiary lymphoid structures in chronic diseases
Sato, Y., Siliņa, K., van den Broek, M. F., Hirahara, K., & Yanagita, M. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00706-z · Cited by 328 · see citing works
Ferretti, A. P., Kula, T., Wang, Y., Nguyen, D. M. V., Weinheimer, A., Dunlap, G. S., Xu, Q., Nabilsi, N., Perullo, C. R., Cristofaro, A. W., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.006 · Cited by 318 · see citing works
Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs
Kern, D. M., Sorum, B., Mali, S. S., Hoel, C., Sridharan, S., Remis, J. P., Toso, D. B., Kotecha, A., Bautista, D. M., & Brohawn, S. G. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00619-0 · Cited by 316 · see citing works
Lessons for COVID-19 immunity from other coronavirus infections
Sariol, A., & Perlman, S. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.005 · Cited by 317 · see citing works
Self-citationRobust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19Preprint
Sekine, T., Perez‐Potti, A., Rivera‐Ballesteros, O., Strålin, K., Gorin, J., Olsson, A., Llewellyn‐Lacey, S., Kamal, H., Bogdanović, G., Muschiol, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.29.174888 · Cited by 272 · see citing works
Prospects for a safe COVID-19 vaccine
Haynes, B. F., Corey, L., Fernandes, P., Gilbert, P. B., Hotez, P. J., Rao, S., Santos, M. R., Schuitemaker, H., Watson, M., & Arvin, A. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abe0948 · Cited by 261 · see citing works
SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection
Altmann, D., & Boyton, R. (2020) · Science immunology · doi:10.1126/sciimmunol.abd6160 · Cited by 255 · see citing works
Ahmed, S. F., Quadeer, A. A., & McKay, M. R. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.03.933226 · Cited by 250 · see citing works
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Martínez-Flores, D., Zepeda–Cervantes, J., Cruz-Reséndiz, A., Aguirre‐Sampieri, S., Sampieri, A., & Vaca, L. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.701501 · Cited by 237 · see citing works
Erasmus, J. H., Khandhar, A. P., O’Connor, M. A., Walls, A. C., Hemann, E. A., Murapa, P., Archer, J., Leventhal, S., Fuller, J. T., Lewis, T. B., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abc9396 · Cited by 241 · see citing works
SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors
Shomuradova, A. S., Vagida, M. S., Sheetikov, S. A., Zornikova, K. V., Kiryukhin, D. O., Titov, A., Peshkova, I. O., Khmelevskaya, A. A., Dianov, D. V., Malasheva, M., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.11.004 · Cited by 222 · see citing works
Tregoning, J. S., Brown, E. S., Cheeseman, H. M., Flight, K. E., Higham, S. L., Lemm, N.-M., Pierce, B. F., Stirling, D. C., Wang, Z., & Pollock, K. M. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13517 · Cited by 222 · see citing works
Rokni, M., Ghasemi, V., & Tavakoli, Z. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2107 · Cited by 222 · see citing works
Honda‐Okubo, Y., Barnard, D. L., Ong, C. H., Peng, B., Tseng, C.-T. K., & Petrovsky, N. (2014) · Journal of Virology · doi:10.1128/jvi.02980-14 · Cited by 204 · see citing works
Dyall, J., Gross, R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Hensley, L. E., Frieman, M. B., & Jahrling, P. B. (2017) · Drugs · doi:10.1007/s40265-017-0830-1 · Cited by 202 · see citing works
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases
Baker, D., Roberts, C. A. K., Pryce, G., Kang, A. S., Marta, M., Reyes, S., Schmierer, K., Giovannoni, G., & Amor, S. (2020) · Clinical and Experimental Immunology · doi:10.1111/cei.13495 · Cited by 192 · see citing works
Adjuvants for Coronavirus Vaccines
Liang, Z., Zhu, H., Wang, X., Jing, B., Li, Z., Xia, X., Sun, H., Yang, Y., Zhang, W., Shi, L., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.589833 · Cited by 199 · see citing works
SARS–CoV-2–specific T cell responses and correlations with COVID-19 patient predisposition
Sattler, A., Angermair, S., Stockmann, H., Heim, K. M., Khadzhynov, D., Treskatsch, S., Halleck, F., Kreis, M. E., & Kotsch, K. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140965 · Cited by 196 · see citing works
Tissue resident memory T cells in the respiratory tract
Zheng, M. Z. M., & Wakim, L. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00461-z · Cited by 177 · see citing works
Wong, L.-Y. R., & Perlman, S. M. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00656-2 · Cited by 196 · see citing works
Thieme, C. J., Anft, M., Paniskaki, K., Blazquez-Navarro, A., Doevelaar, A., Seibert, F. S., Hoelzer, B., Konik, M. J., Berger, M. M., Brenner, T., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100092 · Cited by 184 · see citing works
T Cell Responses to SARS-CoV-2
Sette, A., Sidney, J., & Crotty, S. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101721-061120 · Cited by 181 · see citing works
Gadi, N., Wu, S., Spihlman, A. P., & Moulton, V. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02147 · Cited by 185 · see citing works
Habel, J. R., Nguyen, T. H. O., van de Sandt, C. E., Juno, J. A., Chaurasia, P., Wragg, K. M., Koutsakos, M., Hensen, L., Jia, X., Chua, B. Y. L., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2015486117 · Cited by 182 · see citing works
COVID-19 as an Acute Inflammatory Disease
Manjili, R. H., Zarei, M., Habibi, M., & Manjili, M. H. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000413 · Cited by 176 · see citing works
Rauch, S., Roth, N., Schwendt, K., Fotin-Mleczek, M., Mueller, S. O., & Petsch, B. (2021) · npj Vaccines · doi:10.1038/s41541-021-00311-w · Cited by 165 · see citing works
Innate and adaptive immune responses against coronavirus
Hosseini, A., Hashemi, V., Shomali, N., Asghari, F., Gharibi, T., Akbari, M., Gholizadeh, S., & Jafari, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110859 · Cited by 162 · see citing works
Peripheral and lung resident memory T cell responses against SARS-CoV-2
Grau-Expósito, J., Sánchez-Gaona, N., Massana, N., Suppi, M., Astorga-Gamaza, A., Perea, D., Rosado, J., Falcó-Roget, A., Kirkegaard-Biosca, C., Torrella, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23333-3 · Cited by 161 · see citing works
Molecular Basis of Coronavirus Virulence and Vaccine Development
Enjuanes, L., Zúñiga, S., Castaño-Rodríguez, C., Gutierrez-Alvarez, F. J., Cantón, J., & Sola, I. (2016) · Advances in virus research · doi:10.1016/bs.aivir.2016.08.003 · Cited by 158 · see citing works
Bilich, T., Nelde, A., Heitmann, J. S., Maringer, Y., Roerden, M., Bauer, J., Rieth, J., Wacker, M., Peter, A., Hörber, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf7517 · Cited by 147 · see citing works
Immune responses during COVID-19 infection
Melenotte, C., Silvin, A., Goubet, A., Lahmar, I., Dubuisson, A., Zumla, A. I., Raoult, D., Merad-Boudia, M., Gachot, B., Henon, C., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1807836 · Cited by 162 · see citing works
Antiviral B cell and T cell immunity in the lungs
Chiu, C., & Openshaw, P. (2014) · Nature Immunology · doi:10.1038/ni.3056 · Cited by 151 · see citing works
Adaptive Immune Responses and Immunity to SARS-CoV-2
Primorac, D., Vrdoljak, K., Brlek, P., Pavelić, E., Molnar, V., Matišić, V., Ivkošić, I. E., & Parčina, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.848582 · Cited by 151 · see citing works
Zhou, Y., Zhang, Z., Tian, J., & Xiong, S. (2020) · Annals of Palliative Medicine · doi:10.21037/apm.2020.03.26 · Cited by 144 · see citing works
Antibody Response and Disease Severity in Healthcare Worker MERS Survivors
Alshukairi, A. N., Khalid, I., Ahmed, W., Dada, A. M., Bayumi, D. T., Malic, L. S., Althawadi, S., Ignacio, K. H., Alsalmi, H., Al-Abdely, H. M., et al. (2016) · Emerging infectious diseases · doi:10.3201/eid2206.160010 · Cited by 139 · see citing works
Persistent cellular immunity to SARS-CoV-2 infection
Breton, G., Mendoza, P., Hägglöf, T., Oliveira, T. Y., Schaefer-Babajew, D., Gaebler, C., Turroja, M., Hurley, A., Caskey, M., & Nussenzweig, M. C. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20202515 · Cited by 129 · see citing works
Divergent SARS‐CoV‐2‐specific T‐ and B‐cell responses in severe but not mild COVID‐19 patients
Oja, A. E., Saris, A., Ghandour, C. A., Kragten, N. A. M., Hogema, B. M., Nossent, E. J., Heunks, L. M. A., Cuvalay, S., Slot, E., Linty, F. C., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.202048908 · Cited by 144 · see citing works
Nguyen, T. H. O., Rowntree, L. C., Petersen, J., Chua, B. Y. L., Hensen, L., Kedzierski, Ł., van de Sandt, C. E., Chaurasia, P., Tan, H., Habel, J. R., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.009 · Cited by 131 · see citing works
Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?
Milne, G., Hames, T., Scotton, C. J., Gent, N., Johnsen, A., Anderson, R. M., & Ward, T. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00407-0 · Cited by 121 · see citing works
Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants
Kingstad-Bakke, B. A., Lee, W., Chandrasekar, S., Gasper, D. J., Salas-Quinchucua, C., Cleven, T., Sullivan, J. A., Talaat, A. M., Osorio, J. E., & Suresh, M. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118312119 · Cited by 119 · see citing works
Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection
Schmidt, M. E., Knudson, C. J., Hartwig, S. M., Pewe, L. L., Meyerholz, D. K., Langlois, R. A., Harty, J. T., & Varga, S. M. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006810 · Cited by 123 · see citing works
Gangaev, A., Ketelaars, S. L. C., Isaeva, O. I., Patiwael, S., Dopler, A., Hoefakker, K., De Biasi, S., Gibellini, L., Mussini, C., Guaraldi, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22811-y · Cited by 111 · see citing works
Immune system and COVID-19 by sex differences and age
Ciarambino, T., Para, O., & Giordano, M. (2021) · Women s Health · doi:10.1177/17455065211022262 · Cited by 139 · see citing works
Oliveira, S. C., de Magalhães, M. T. Q., & Homan, E. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.587615 · Cited by 115 · see citing works
Shah, P., Canziani, G., Carter, E. P., & CHAIKEN, I. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637651 · Cited by 115 · see citing works
Guo, X., Deng, Y. L., Chen, H., Lan, J., Wang, W., Zou, X., Hung, T., Lu, Z., & Tan, W. (2015) · Immunology · doi:10.1111/imm.12462 · Cited by 111 · see citing works
T cell immunity to SARS-CoV-2 following natural infection and vaccination
DiPiazza, A. T., Graham, B. S., & Ruckwardt, T. J. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.060 · Cited by 107 · see citing works
SARS-CoV-2 infections in children and young people
Felsenstein, S., & Hedrich, C. M. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108588 · Cited by 109 · see citing works
What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?
Rosales‐Mendoza, S., Márquez-Escobar, V. A., González‐Ortega, O., Nieto‐Gómez, R., & Arévalo-Villalobos, J. I. (2020) · Vaccines · doi:10.3390/vaccines8020183 · Cited by 103 · see citing works
Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome
Crooke, S. N., Ovsyannikova, I. G., Kennedy, R. B., & Poland, G. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-70864-8 · Cited by 104 · see citing works
Poran, A., Harjanto, D., Malloy, M., Arieta, C. M., Rothenberg, D. A., Lenkala, D., van Buuren, M. M., Addona, T. A., Rooney, M. S., Srinivasan, L., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00767-w · Cited by 102 · see citing works
Zhang, Y.-Y., Li, B.-R., & Ning, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02033 · Cited by 103 · see citing works
Channappanavar, R., & Perlman, S. M. (2020) · Journal of Clinical Investigation · doi:10.1172/jci144115 · Cited by 92 · see citing works
Potential T-cell and B-cell Epitopes of 2019-nCoVPreprint
Fast, E., Altman, R. B., & Chen, B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.19.955484 · Cited by 90 · see citing works
Maruggi, G., Mallett, C. P., Westerbeck, J. W., Chen, T., Lofano, G., Friedrich, K., Qu, L., Sun, J., McAuliffe, J., Kanitkar, A. P., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.001 · Cited by 88 · see citing works
The CD4 T cell response to respiratory syncytial virus infection
Christiaansen, A. F., Knudson, C. J., Weiss, K. A., & Varga, S. M. (2014) · Immunologic Research · doi:10.1007/s12026-014-8540-1 · Cited by 88 · see citing works
The clinical and immunological features of pediatric COVID-19 patients in China
Chen, J., Zhang, Z., Chen, Y., Long, Q., Tian, W., Deng, H., Hu, J., Zhang, X., Pu-Liao, Xiang, J., et al. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.03.008 · Cited by 87 · see citing works
Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses
Nathan, A., Rossin, E. J., Kaseke, C., Park, R. J.-H., Khatri, A., Koundakjian, D., Urbach, J. M., Singh, N. K., Bashirova, A. A., Tano-Menka, R., et al. (2021) · Cell · doi:10.1016/j.cell.2021.06.029 · Cited by 84 · see citing works
Arieta, C. M., Xie, Y. J., Rothenberg, D., Diao, H., Harjanto, D., Meda, S., Marquart, K., Koenitzer, B., Sciuto, T. E., Lobo, A., et al. (2023) · Cell · doi:10.1016/j.cell.2023.04.007 · Cited by 85 · see citing works
Malone, B., Simovski, B., Moliné, C., Cheng, J., Gheorghe, M., Fontenelle, H., Vardaxis, I., Tennøe, S., Malmberg, J.-A., Stratford, R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-78758-5 · Cited by 85 · see citing works
An Effective COVID-19 Vaccine Needs to Engage T Cells
Sauer, K., & Harris, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.581807 · Cited by 84 · see citing works
Hellerstein, M. K. (2020) · Vaccine X · doi:10.1016/j.jvacx.2020.100076 · Cited by 81 · see citing works
SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis
Aghbash, P. S., Eslami, N., Shamekh, A., Entezari‐Maleki, T., & Baghi, H. B. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119124 · Cited by 83 · see citing works
Wu, Y., Huang, X., Yuan, L., Wang, S., Zhang, Y., Xiong, H., Chen, R., Ma, J., Qi, R., Nie, M., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abg1143 · Cited by 82 · see citing works
Künzli, M., O’Flanagan, S. D., LaRue, M., Talukder, P., Dileepan, T., Stolley, J. M., Soerens, A. G., Quarnstrom, C. F., Wijeyesinghe, S., Ye, Y., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.add3075 · Cited by 80 · see citing works
Multiscale PHATE identifies multimodal signatures of COVID-19
Kuchroo, M., Huang, J., Wong, P., Grenier, J.-C., Shung, D., Tong, A., Lucas, C., Klein, J., Burkhardt, D. B., Gigante, S., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01186-x · Cited by 72 · see citing works
Antunes, R. D. S., Pallikkuth, S., Williams, E., Yu, E. D., Mateus, J., Quiambao, L. G., Wang, E. W., Rawlings, S. A., Stadlbauer, D., Jiang, K., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab176 · Cited by 70 · see citing works
Charmetant, X., Espi, M., Benotmane, I., Barateau, V., Heibel, F., Buron, F., Gautier-Vargas, G., Delafosse, M., Perrin, P., Koenig, A., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl6141 · Cited by 77 · see citing works
Baker, D., Amor, S., Kang, A. S., Schmierer, K., & Giovannoni, G. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102174 · Cited by 76 · see citing works
Niessl, J., Sekine, T., & Buggert, M. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101505 · Cited by 74 · see citing works
Johnson, R. F., Bağcı, U., Keith, L. A., Tang, X., Mollura, D. J., Zeitlin, L., Qin, J., Huzella, L., Bartos, C., Bohorova, N., et al. (2016) · Virology · doi:10.1016/j.virol.2016.01.004 · Cited by 76 · see citing works
Role of iBALT in Respiratory Immunity
Silva-Sánchez, A., & Randall, T. D. (2019) · Current topics in microbiology and immunology · doi:10.1007/82_2019_191 · Cited by 75 · see citing works
Saletti, G., Gerlach, T. H., Jansen, J. M., Molle, A., Elbahesh, H., Ludlow, M., Li, W., Bosch, B., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2020) · Scientific Reports · doi:10.1038/s41598-020-78506-9 · Cited by 75 · see citing works
In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives
Sohail, M. S., Ahmed, S. F., Quadeer, A. A., & McKay, M. R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.007 · Cited by 75 · see citing works
The BCG Vaccine for COVID-19: First Verdict and Future Directions
González-Pérez, M., Sánchez-Tarjuelo, R., Shor, B., Nistal‐Villán, E., & Ochando, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632478 · Cited by 74 · see citing works
Gittelman, R. M., Lavezzo, E., Snyder, T. M., Zahid, H. J., Carty, C. L., Elyanow, R., Dalai, S. C., Kirsch, I. R., Baldo, L., Manuto, L., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.151849 · Cited by 74 · see citing works
- Authors
- Channappanavar, R., Fett, C., Zhao, J., Meyerholz, D. K., & Perlman, S.
- Affiliations
- University of Iowa (US)
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2014-10
- Volume
- 88
- Issue
- 19
- Pages
- 11034-11044
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC4178831
- OpenAlex
- W2004583429
- Cited by
- 411
- References
- 53
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 14 · 2023: 39 · 2022: 51 · 2021: 117 · 2020: 142 · 2019: 3 · 2018: 6 · 2017: 4 · 2016: 6 · 2015: 3 · 2014: 3
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AI060699)
- National Institute of Allergy and Infectious Diseases (AI091322, R01AI091322, AI060699, P01AI060699)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK054759)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- SARS-CoV, memory CD8+ T cells, T cell immunity, immunodominant epitopes, spike protein, prime-boost vaccination, peptide-loaded dendritic cells, vaccinia virus vector, lung viral load, cytokine production, granzyme B
- MeSH terms
- Animals, Antibodies, Viral, Antigens, Viral, Dendritic Cells, Female, Humans, Immunity, Active, Immunity, Cellular, Immunization, Immunologic Memory, Peptides, CD4-Positive T-Lymphocytes, Gene Expression, Survival Analysis, CD8-Positive T-Lymphocytes, Epitopes, T-Lymphocyte, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus, Mice, Immunity, Humoral
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
